Approximately one-quarter of all cardiac tumors present with systemic embolization. 1 Cardiac papillary fibroelastomas (CPF) represent a potential embolic source, accounting for 8% of all primary cardiac tumors, second in frequency after cardiac myxomas. 2 Most case reports describe papillary fibroelastoma as a potential source for stroke, 3 but histopathological evidence of actual tumor fragment causing a stroke is lacking. We describe a case of histologically confirmed CPF mechanically retrieved from a cerebral artery during an emergent cerebral endovascular procedure with subsequent discovery of the CPF in the heart, providing in vivo demonstration of intracranial embolization of this cardiac tumor.
CASE REPORT
A 62-year-old Caucasian man with history of hypertension, hyperlipidemia, coronary artery disease, and tobacco use presented to an outside hospital with acute onset of right-sided weakness and global aphasia. His National Institutes of Health Stroke Scale score was 24. A CT scan of the brain showed no hemorrhage, and intravenous tissue plasminogen activator was started 3.5 hours after symptom onset without improvement. An MRI and a magnetic resonance angiogram of the brain showed an M1 middle cerebral artery occlusion with diffusion restriction limited to the deep structures and significant mismatch between diffusion and perfusion imaging.
The patient was transferred to our institution three hours later with no clinical change. Repeat MRI and magnetic resonance angiogram were stable. Because of the clinical diffusion and diffusion perfusion mismatch, he underwent emergent intra-arterial stroke therapy. Mechanical thrombectomy was performed using a Solitaire stent retriever (Covidien Inc, Irvine, CA). Thrombolysis in cerebral infarction grade 2b was achieved after a single attempt. The stent retriever was removed with embolus, which was noted to have a "jellylike" texture ( Figure 1 ). Pathology review of the embolus revealed a papillary mass consistent with a papillary fibroelastoma with no associated thrombus (Figure 2A, B ).
Postprocedural brain MRI showed a stable infarct size. Stroke workup including a transthoracic echocardiogram was normal. A transesophageal echocardiogram was attempted, but was not tolerated by the patient. He was discharged to a rehabilitation center. A few weeks later, the transesophageal echocardiogram was reattempted, which revealed a mobile left atrial mass measuring 23 × 16 × 14 mm. The patient was admitted for open heart surgery and the mass was excised from the left atrium and confirmed to have matching microscopic characteristics of the inciting embolism ( Figure 2C ). The patient continued to improve, and at his three-month follow-up was ambulating (National Institute of Health Stroke Scale = 10; modified Rankin Score = 3).
DISCUSSION
Our case represents a rare demonstration of in vivo retrieval of histologically confirmed CPF, which was mechanically retrieved from the middle cerebral artery during an emergent cerebral endovascular procedure, providing direct evidence of the embolization potential of this tumor. This embolic risk has been recently described in several case reports. [4] [5] [6] Primary cardiac tumors are rare, accounting for <1% of ischemic strokes, 7 are often discovered on follow-up echocardiogram after a stroke. CPF mostly originate from the valvular endocardium (85%) and involve the aortic (29%), mitral (25%), tricuspid (17%), and pulmonary valves (13%) in decreasing order of frequency. 8 They are noted to have multiple frond-like projections on an underlying pedicle, giving them the appearance of a sea anemone. They are usually solitary, but some patients have multiple tumors throughout the left-sided chambers. The symptomatic presentation of CPF includes ischemic stroke, syncope, congestive heart failure, and ventricular arrhythmias. 5 The origin of these tumors is unclear. Thoracic radiation or cardiac surgeries may be potential causes, and the tumors may also be related to organizing thrombi resulting from the presence of fibrin, hyaluronic acid, and laminated elastic fibers. 9 CPF have no known malignant potential but are considered dangerous because of their propensity to embolize. Left-sided tumors present with systemic embolization, whereas right-sided tumors remain predominantly asymptomatic until large enough to interfere with intracardiac blood flow, alter hemodynamic function, or induce arrhythmias.
Management of CPF has remained controversial. Although early tumor removal has been proposed in some instances, an incidental finding of CPF on echocardiogram does not necessarily lead to a surgical referral. One of the reasons is the uncertainty of risk of embolization, along with the fear of surgical complications. Elbardissi et al demonstrated a 25% rate of embolization of all cardiac tumors, but did not stratify this risk according to tumor type. 1 Once diagnosed following a stroke, symptomatic CPF management is removal of tumor to prevent further embolic events. The outcome of such strokes is dependent on the extent and size of the infarct, and there are not enough data to predict if clot composition itself predicts the outcome of stroke. Timing of cardiac surgery is of critical importance because a large-territory infarct is at risk of bleeding during cardiopulmonary bypass in the acute setting, whereas waiting too long may lead to further embolic events. Surgical management follows a period of watchful waiting, and the patient's modifiable stroke risk factors are addressed in the interim to prevent any further stroke.
Advancement in endovascular management of stroke has allowed us to identify potential sources of emboli by routine histopathological analysis of extracted clot products. Pathologic examination may allow the identification of primary cardiac tumors, as evidenced in this case. Existing studies suggest such tumors should be surgically removed to prevent future embolic risks. 
